StreetInsider.com News Articles

MMA.INC partners with Precision Peptide in 50/50 revenue share deal

Tue, 12 May 2026 08:31:50 -0400

Mixed Martial Arts Group Limited (NYSE American: MMA) announced an exclusive marketing partnership with The Precision Peptide Company Inc. (CSE: BPC; OTCQB: PNGAF) to sell peptide recovery products across its global combat sports network.

Under the agreement, MMA.INC will receive 50% of net revenue from sales generated through its platform during the first twelve months, followed by 25% of net revenue for the remainder of the partnership term. The company will market Precision's U.S.-manufactured and third-party tested peptide products through its ecosystem of platforms including TrainAlta, BJJLink, and MixedMartialArts.com.

The partnership can be terminated by either party with 30 days written notice.

MMA.INC partners with Precision Peptide in 50/50 revenue share deal

Tue, 12 May 2026 08:31:50 -0400

The partnership can be terminated by either party with 30 days written notice.

MMA.INC partners with Precision Peptide in 50/50 revenue share deal

Tue, 12 May 2026 08:31:50 -0400

The partnership can be terminated by either party with 30 days written notice.

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC)

Tue, 12 May 2026 08:30:00 -0400

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
MMA.INC to participate directly in revenue generated across its global customer base
Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

New York,

BP plc (BP) to Receive $4B in Anadarko (APC) Macondo Settlement, Will Apply to $20B Fund

Mon, 17 Oct 2011 06:22:08 -0400
si-local-file:///var/storage/newsbody/2011/1017/6858625.html

BP plc (BP) to Receive $4B in Anadarko (APC) Macondo Settlement, Will Apply to $20B Fund

Mon, 17 Oct 2011 06:22:08 -0400
si-local-file:///var/storage/newsbody/2011/1017/6858625.html

BP plc (BP) to Receive $4B in Anadarko (APC) Macondo Settlement, Will Apply to $20B Fund

Mon, 17 Oct 2011 06:22:08 -0400
si-local-file:///var/storage/newsbody/2011/1017/6858625.html

BP plc (BP) to Receive $4B in Anadarko (APC) Macondo Settlement, Will Apply to $20B Fund

Mon, 17 Oct 2011 06:22:08 -0400
si-local-file:///var/storage/newsbody/2011/1017/6858625.html

BP plc (BP) to Receive $4B in Anadarko (APC) Macondo Settlement, Will Apply to $20B Fund

Mon, 17 Oct 2011 06:22:08 -0400
si-local-file:///var/storage/newsbody/2011/1017/6858625.html